Cargando…

Monoclonal antibodies targeting the influenza virus N6 neuraminidase

Influenza A viruses are a diverse species that include 16 true hemagglutinin (HA) subtypes and 9 true neuraminidase (NA) subtypes. While the antigenicity of many HA subtypes is reasonably well studied, less is known about NA antigenicity, especially when it comes to non-human subtypes that only circ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strohmeier, Shirin, Amanat, Fatima, Carreño, Juan Manuel, Krammer, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9363587/ https://www.ncbi.nlm.nih.gov/pubmed/35967389 http://dx.doi.org/10.3389/fimmu.2022.944907

Ejemplares similares

Introduction of Cysteines in the Stalk Domain of Recombinant Influenza Virus N1 Neuraminidase Enhances Protein Stability and Immunogenicity in Mice
por: Strohmeier, Shirin, et al.
Publicado: (2021)

Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies
por: Kirkpatrick Roubidoux, Ericka, et al.
Publicado: (2022)

Cross-Reactive Antibodies Binding to the Influenza Virus Subtype H11 Hemagglutinin
por: Strohmeier, Shirin, et al.
Publicado: (2019)

Cross-reactive antibodies binding to H4 hemagglutinin protect against a lethal H4N6 influenza virus challenge in the mouse model
por: Amanat, Fatima, et al.
Publicado: (2019)

A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice
por: Strohmeier, Shirin, et al.
Publicado: (2022)

Cross-reactive mouse monoclonal antibodies raised against the hemagglutinin of A/Shanghai/1/2013 (H7N9) protect against novel H7 virus isolates in the mouse model
por: Stadlbauer, Daniel, et al.
Publicado: (2018)

Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site
por: Stadlbauer, Daniel, et al.
Publicado: (2022)

Broadly protective murine monoclonal antibodies against influenza B virus target highly conserved neuraminidase epitopes
por: Wohlbold, Teddy John, et al.
Publicado: (2017)

A Novel Recombinant Influenza Virus Neuraminidase Vaccine Candidate Stabilized by a Measles Virus Phosphoprotein Tetramerization Domain Provides Robust Protection from Virus Challenge in the Mouse Model
por: Strohmeier, Shirin, et al.
Publicado: (2021)

Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs
por: McMahon, Meagan, et al.
Publicado: (2019)

Identification and Characterization of Novel Antibody Epitopes on the N2 Neuraminidase
por: Kirkpatrick Roubidoux, Ericka, et al.
Publicado: (2021)

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
por: Rajendran, Madhusudan, et al.
Publicado: (2017)

Murine Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2 Neutralize Authentic Wild-Type SARS-CoV-2 as Well as B.1.1.7 and B.1.351 Viruses and Protect In Vivo in a Mouse Model in a Neutralization-Dependent Manner
por: Amanat, Fatima, et al.
Publicado: (2021)

The Human Antibody Response to the Influenza Virus Neuraminidase Following Infection or Vaccination
por: Rajendran, Madhusudan, et al.
Publicado: (2021)

Immunity induced by vaccination with recombinant influenza B virus neuraminidase protein breaks viral transmission chains in guinea pigs in an exposure intensity-dependent manner
por: McMahon, Meagan, et al.
Publicado: (2022)

Non-sterilizing, Infection-Permissive Vaccination With Inactivated Influenza Virus Vaccine Reshapes Subsequent Virus Infection-Induced Protective Heterosubtypic Immunity From Cellular to Humoral Cross-Reactive Immune Responses
por: Choi, Angela, et al.
Publicado: (2020)

Mosaic Hemagglutinin-Based Whole Inactivated Virus Vaccines Induce Broad Protection Against Influenza B Virus Challenge in Mice
por: Liu, Yonghong, et al.
Publicado: (2021)

Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults
por: Meade, Philip, et al.
Publicado: (2020)

Differential recognition of influenza A virus H1N1 neuraminidase by DNA vaccine-induced antibodies in pigs and ferrets
por: Tingstedt, Jeanette Linnea, et al.
Publicado: (2023)

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
por: Leang, Sook-Kwan, et al.
Publicado: (2017)

Protective efficacy of anti-neuraminidase monoclonal antibodies against H7N9 influenza virus infection
por: Xiong, Fei-Fei, et al.
Publicado: (2020)

Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers
por: Hansen, Lena, et al.
Publicado: (2021)

Generation of a recombinant chickenized monoclonal antibody against the neuraminidase of H9N2 avian influenza virus
por: Wang, Fei, et al.
Publicado: (2020)

Measuring Influenza Neuraminidase Inhibition Antibody Titers by Enzyme-linked Lectin Assay
por: Gao, Jin, et al.
Publicado: (2016)

Influenza Neuraminidase Characteristics and Potential as a Vaccine Target
por: Creytens, Sarah, et al.
Publicado: (2021)

Study of Antibodies to Influenza Neuraminidase N2
por: Desheva, Yulia, et al.
Publicado: (2022)

H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model
por: Carreño, Juan Manuel, et al.
Publicado: (2020)

A broadly protective human monoclonal antibody targeting the sialidase activity of influenza A and B virus neuraminidases
por: Yasuhara, Atsuhiro, et al.
Publicado: (2022)

Broadly Protective Neuraminidase-Based Influenza Vaccines and Monoclonal Antibodies: Target Epitopes and Mechanisms of Action
por: Abbadi, Nada, et al.
Publicado: (2023)

Immunity to Seasonal Coronavirus Spike Proteins Does Not Protect from SARS-CoV-2 Challenge in a Mouse Model but Has No Detrimental Effect on Protection Mediated by COVID-19 mRNA Vaccination
por: Amanat, Fatima, et al.
Publicado: (2023)

Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components
por: Hernandez-Davies, Jenny E., et al.
Publicado: (2021)

Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies
por: Piepenbrink, Michael, et al.
Publicado: (2023)

Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus
por: Arunkumar, Guha Asthagiri, et al.
Publicado: (2021)

Introduction of two prolines and removal of the polybasic cleavage site leads to optimal efficacy of a recombinant spike based SARS-CoV-2 vaccine in the mouse model
por: Amanat, Fatima, et al.
Publicado: (2020)

Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
por: Amanat, Fatima, et al.
Publicado: (2021)

A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model
por: Pliasas, Vasilis C., et al.
Publicado: (2022)

Antibody Neutralization of an Influenza Virus that Uses Neuraminidase for Receptor Binding
por: Gentles, Lauren E., et al.
Publicado: (2020)

An In Vitro Microneutralization Assay for Influenza Virus Serology
por: Cuevas, Frans, et al.
Publicado: (2022)

Low Dose Pig Anti-Influenza Virus Monoclonal Antibodies Reduce Lung Pathology but Do Not Prevent Virus Shedding
por: Paudyal, Basudev, et al.
Publicado: (2021)

A universal monoclonal antibody protects against all influenza A and B viruses by targeting a highly conserved epitope in the viral neuraminidase
por: Doyle, Tracey M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7v3tmc1fnipbffg9ha4iml3et0